American Research Development vs Cost Of Revenue Analysis

AMWL Stock

USD 10.14 0.25 2.41%

American Well financial indicator trend analysis is way more than just evaluating American Well Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether American Well Corp is a good investment. Please check the relationship between American Well Research Development and its Cost Of Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Well Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of American Well Corp Research Development account and Cost Of Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between American Well's Research Development and Cost Of Revenue is 0.95. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of American Well Corp, assuming nothing else is changed. The correlation between historical values of American Well's Research Development and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of American Well Corp are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Research Development i.e., American Well's Research Development and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Cost Of Revenue

Cost of Revenue is found on American Well Corp income statement and represents the costs associated with goods and services American Well provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from American Well's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into American Well Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Well Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

At this time, American Well's Tax Provision is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 0.63 this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.37.

	2022	2023	2024	2025 (projected)
Interest Income	6.1M	15.3M	10.8M	6.6M
Net Interest Income	6.1M	15.3M	10.8M	6.6M

Interest Income Net Interest Income

American Well fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab
Total Assets		0.68	0.81	0.92	-0.36	0.74	0.72	0.01	-0.94	-0.19	0.77	0.94	0.79	-0.23	0.6	0.93	0.44	0.74	0.62	-0.68	-0.67	0.9	0.71	0.64	-0.65	0.06
Other Current Liab	0.68		0.89	0.86	-0.77	0.88	0.9	-0.52	-0.76	-0.78	0.77	0.76	0.53	0.49	0.71	0.57	0.91	0.34	0.93	-0.87	-0.92	0.71	0.73	0.89	-0.9	0.65
Total Current Liabilities	0.81	0.89		0.87	-0.54	0.81	0.89	-0.17	-0.81	-0.53	0.91	0.81	0.61	0.08	0.64	0.71	0.69	0.48	0.74	-0.75	-0.78	0.66	0.61	0.71	-0.76	0.26
Total Stockholder Equity	0.92	0.86	0.87		-0.6	0.94	0.78	-0.33	-0.95	-0.55	0.74	0.95	0.63	0.12	0.78	0.88	0.73	0.5	0.86	-0.91	-0.91	0.9	0.78	0.88	-0.89	0.37
Other Liab	-0.36	-0.77	-0.54	-0.6		-0.72	-0.65	0.65	0.56	0.75	-0.26	-0.56	-0.11	-0.63	-0.84	-0.37	-0.78	0.04	-0.77	0.68	0.75	-0.58	-0.54	-0.7	0.75	-0.64
Net Tangible Assets	0.74	0.88	0.81	0.94	-0.72		0.69	-0.5	-0.87	-0.75	0.59	0.86	0.34	0.32	0.88	0.77	0.86	0.18	0.94	-0.98	-0.98	0.77	0.65	0.95	-0.98	0.52
Property Plant And Equipment Net	0.72	0.9	0.89	0.78	-0.65	0.69		-0.31	-0.73	-0.54	0.88	0.74	0.66	0.25	0.54	0.56	0.64	0.51	0.71	-0.65	-0.71	0.71	0.67	0.65	-0.69	0.36
Current Deferred Revenue	0.01	-0.52	-0.17	-0.33	0.65	-0.5	-0.31		0.1	0.85	-0.03	-0.1	0.12	-0.85	-0.41	0.06	-0.7	0.3	-0.6	0.61	0.63	-0.21	-0.54	-0.63	0.65	-0.81
Net Debt	-0.94	-0.76	-0.81	-0.95	0.56	-0.87	-0.73	0.1		0.36	-0.68	-1.0	-0.61	0.07	-0.8	-0.96	-0.57	-0.52	-0.76	0.79	0.79	-0.94	-0.62	-0.76	0.77	-0.18
Retained Earnings	-0.19	-0.78	-0.53	-0.55	0.75	-0.75	-0.54	0.85	0.36		-0.33	-0.36	0.04	-0.81	-0.62	-0.17	-0.92	0.26	-0.84	0.81	0.84	-0.32	-0.48	-0.83	0.85	-0.82
Accounts Payable	0.77	0.77	0.91	0.74	-0.26	0.59	0.88	-0.03	-0.68	-0.33		0.68	0.78	-0.03	0.3	0.58	0.49	0.67	0.57	-0.56	-0.58	0.59	0.58	0.54	-0.55	0.15
Cash	0.94	0.76	0.81	0.95	-0.56	0.86	0.74	-0.1	-1.0	-0.36	0.68		0.62	-0.06	0.79	0.95	0.58	0.53	0.76	-0.78	-0.79	0.94	0.62	0.76	-0.77	0.19
Non Current Assets Total	0.79	0.53	0.61	0.63	-0.11	0.34	0.66	0.12	-0.61	0.04	0.78	0.62		-0.16	0.12	0.54	0.26	0.97	0.39	-0.34	-0.34	0.69	0.72	0.36	-0.31	0.11
Non Currrent Assets Other	-0.23	0.49	0.08	0.12	-0.63	0.32	0.25	-0.85	0.07	-0.81	-0.03	-0.06	-0.16		0.26	-0.31	0.71	-0.34	0.57	-0.43	-0.48	0.04	0.32	0.52	-0.49	0.93
Other Assets	0.6	0.71	0.64	0.78	-0.84	0.88	0.54	-0.41	-0.8	-0.62	0.3	0.79	0.12	0.26		0.73	0.72	0.01	0.79	-0.8	-0.83	0.7	0.48	0.77	-0.83	0.38
Cash And Short Term Investments	0.93	0.57	0.71	0.88	-0.37	0.77	0.56	0.06	-0.96	-0.17	0.58	0.95	0.54	-0.31	0.73		0.38	0.5	0.59	-0.68	-0.66	0.87	0.52	0.62	-0.64	-0.05
Net Receivables	0.44	0.91	0.69	0.73	-0.78	0.86	0.64	-0.7	-0.57	-0.92	0.49	0.58	0.26	0.71	0.72	0.38		0.05	0.96	-0.9	-0.92	0.53	0.64	0.93	-0.92	0.85
Good Will	0.74	0.34	0.48	0.5	0.04	0.18	0.51	0.3	-0.52	0.26	0.67	0.53	0.97	-0.34	0.01	0.5	0.05		0.19	-0.16	-0.15	0.6	0.61	0.17	-0.12	-0.08
Common Stock Total Equity	0.62	0.93	0.74	0.86	-0.77	0.94	0.71	-0.6	-0.76	-0.84	0.57	0.76	0.39	0.57	0.79	0.59	0.96	0.19		-0.96	-0.97	0.74	0.69	0.98	-0.97	0.75
Common Stock Shares Outstanding	-0.68	-0.87	-0.75	-0.91	0.68	-0.98	-0.65	0.61	0.79	0.81	-0.56	-0.78	-0.34	-0.43	-0.8	-0.68	-0.9	-0.16	-0.96		0.99	-0.74	-0.7	-0.99	0.99	-0.63
Non Current Liabilities Total	-0.67	-0.92	-0.78	-0.91	0.75	-0.98	-0.71	0.63	0.79	0.84	-0.58	-0.79	-0.34	-0.48	-0.83	-0.66	-0.92	-0.15	-0.97	0.99		-0.74	-0.71	-0.98	1.0	-0.65
Inventory	0.9	0.71	0.66	0.9	-0.58	0.77	0.71	-0.21	-0.94	-0.32	0.59	0.94	0.69	0.04	0.7	0.87	0.53	0.6	0.74	-0.74	-0.74		0.74	0.74	-0.72	0.29
Other Current Assets	0.71	0.73	0.61	0.78	-0.54	0.65	0.67	-0.54	-0.62	-0.48	0.58	0.62	0.72	0.32	0.48	0.52	0.64	0.61	0.69	-0.7	-0.71	0.74		0.71	-0.7	0.54
Other Stockholder Equity	0.64	0.89	0.71	0.88	-0.7	0.95	0.65	-0.63	-0.76	-0.83	0.54	0.76	0.36	0.52	0.77	0.62	0.93	0.17	0.98	-0.99	-0.98	0.74	0.71		-0.98	0.73
Total Liab	-0.65	-0.9	-0.76	-0.89	0.75	-0.98	-0.69	0.65	0.77	0.85	-0.55	-0.77	-0.31	-0.49	-0.83	-0.64	-0.92	-0.12	-0.97	0.99	1.0	-0.72	-0.7	-0.98		-0.66
Deferred Long Term Liab	0.06	0.65	0.26	0.37	-0.64	0.52	0.36	-0.81	-0.18	-0.82	0.15	0.19	0.11	0.93	0.38	-0.05	0.85	-0.08	0.75	-0.63	-0.65	0.29	0.54	0.73	-0.66

Click cells to compare fundamentals

American Well Account Relationship Matchups

American Well fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.4B	1.4B	1.2B	589.7M	436.0M	692.0M
Other Current Liab	35.8M	56.8M	51.2M	39.0M	49.3M	41.6M
Total Current Liabilities	121.0M	141.6M	114.1M	93.8M	111.3M	122.0M
Total Stockholder Equity	1.2B	1.2B	1.1B	464.2M	304.8M	590.4M
Other Liab	11.2M	8.2M	28.6M	7.9M	7.1M	13.8M
Net Tangible Assets	(564.5M)	974.7M	644.1M	493.6M	567.7M	596.0M
Property Plant And Equipment Net	10.4M	18.7M	14.5M	11.0M	7.6M	12.6M
Current Deferred Revenue	66.7M	68.8M	49.5M	46.4M	53.2M	47.5M
Net Debt	(934.0M)	(729.8M)	(523.7M)	(360.3M)	(220.1M)	(231.1M)
Retained Earnings	(582.4M)	(811.3M)	(1.1B)	(1.8B)	(2.0B)	(1.9B)
Accounts Payable	5.8M	12.2M	7.2M	4.9M	5.0M	7.2M
Cash	941.6M	746.4M	538.5M	372.0M	228.3M	216.9M
Non Current Assets Total	263.4M	618.5M	590.9M	140.1M	119.0M	113.0M
Non Currrent Assets Other	1.4M	2.5M	6.2M	7.7M	8.4M	5.3M
Other Assets	4.3M	10.1M	4.5M	6.2M	7.1M	6.3M
Cash And Short Term Investments	1.0B	746.4M	538.5M	372.0M	228.3M	384.1M
Net Receivables	45.3M	51.4M	58.4M	54.1M	71.9M	54.1M
Common Stock Total Equity	423K	2.4M	2.6M	2.8M	3.2M	1.9M
Common Stock Shares Outstanding	5.0M	12.7M	13.7M	14.2M	15.0M	14.2M
Liabilities And Stockholders Equity	1.4B	1.4B	1.2B	589.7M	436.0M	692.0M
Non Current Liabilities Total	9.5M	43.3M	19.7M	15.7M	8.5M	8.0M
Capital Lease Obligations	7.7M	16.6M	14.8M	11.8M	8.2M	11.4M
Inventory	9.1M	7.5M	8.7M	6.7M	2.9M	2.7M
Other Current Assets	17.3M	22.0M	40.5M	16.7M	13.9M	20.6M
Other Stockholder Equity	1.8B	2.1B	2.2B	2.2B	2.3B	1.6B
Total Liab	130.4M	185.0M	133.7M	109.5M	119.7M	113.7M
Deferred Long Term Liab	1.6M	1.3M	2.0M	3.4M	3.9M	2.2M
Net Invested Capital	1.2B	1.2B	1.1B	464.2M	304.8M	590.4M
Property Plant And Equipment Gross	10.4M	18.7M	14.5M	23.8M	20.7M	16.6M
Total Current Assets	1.1B	827.3M	626.6M	449.6M	317.0M	606.2M
Accumulated Other Comprehensive Income	297K	(6.4M)	(17.0M)	(15.7M)	(15.8M)	(15.0M)
Capital Stock	2.4M	2.6M	2.8M	2.9M	156K	148.2K
Non Current Liabilities Other	64K	21.6M	1.6M	1.4M	1.2M	1.1M
Net Working Capital	992.3M	685.7M	512.6M	355.8M	205.7M	352.2M
Short Term Debt	12.7M	3.8M	6.1M	7.9M	3.7M	6.3M
Intangible Assets	55.5M	152.4M	135.0M	120.2M	101.5M	107.4M
Common Stock	2.4M	2.6M	2.8M	2.9M	156K	148.2K
Property Plant Equipment	14.6M	10.4M	18.7M	1.0M	910.8K	865.3K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether American Well Corp is a strong investment it is important to analyze American Well's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact American Well's future performance. For an informed investment choice regarding American Stock, refer to the following important reports:

How To Invest In American

Details

Is American Stock a good investment?

Details

What is American Well's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Well Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Well. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Well listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(13.55)

Revenue Per Share

16.958

Quarterly Revenue Growth

0.005

Return On Assets

(0.24)

Return On Equity

(0.53)

The market value of American Well Corp is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Well's value that differs from its market value or its book value, called intrinsic value, which is American Well's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Well's market value can be influenced by many factors that don't directly affect American Well's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between American Well's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Well is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Well's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

American Research Development vs Cost Of Revenue Analysis

Research Development vs Cost Of Revenue

Research Development vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Research Development

Cost Of Revenue

American Well fundamental ratios Correlations

American Well Account Relationship Matchups

High Positive Relationship

High Negative Relationship

American Well fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Common Stock Shares Outstanding
Other Stockholder Equity	+ 0.98	Common Stock Total Equity
Good Will	+ 0.97	Non Current Assets Total
Common Stock Total Equity	+ 0.96	Net Receivables

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Common Stock Shares Outstanding
Total Liab	- 0.98	Other Stockholder Equity
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Total Liab	- 0.98	Net Tangible Assets
Non Current Liabilities Total	- 0.98	Net Tangible Assets